-
-
-
-
-
-
-
Vertex (VRTX) PT Lowered to $436 at Canaccord
-
-
-
-
-
-
-
Bernstein on US Pharma and Biotech: Who might buy whom?
-
-
-
-
-
-
-
Vertex (VRTX) PT Raised to $520 at Argus
-
-
-
-
-
-
-
Jefferies Starts Vertex (VRTX) at Buy
-
-
-
-
-
-
-
Vertex (VRTX) PT Raised to $600 at BMO Capital
-
-
-
-
-
-
-
RBC Capital Upgrades Vertex (VRTX) to Outperform
-
-
-
-
-
-
-
BofA: 'Top SMid Biotech Picks Argenx, KalVista, Ocular, and Vertex'
-
409,659 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

